Terumo to buy OrganOx for $1.5B to enter transplant field

OrganOx could capture a greater share of the liver transplant market, where it competes with TransMedics Group, Needham analyst Mike Matson wrote.

By Susan Kelly • Aug. 25, 2025

Medtech firms shuffle execs in 2025

Top leaders at Intuitive, Boston Scientific, Dexcom and others changed roles this year. Read MedTech Dive’s roundup for all the details.

By Elise Reuter • Aug. 25, 2025

Explore the Trendline➔

Top 5 stories from MedTech Dive

From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

Sustainable medical device packaging solutions: Mono-materials that perform

Mono-material packaging meets tough healthcare demands while improving recyclability.

Aug. 25, 2025

Boston Scientific recalls carotid stents over manufacturing defect

The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and cause a stroke.

By Nick Paul Taylor • Aug. 25, 2025

The robotic surgery market battle is heating up

After a busy summer of surgical robotics news, check out MedTech Dive’s roundup of coverage in the space.

By Susan Kelly • Aug. 22, 2025

MedTech Europe sounds alarm over impact of US-EU tariffs on patients

The trade group wants the U.S. to eliminate tariffs on medical technologies, warning that “patients cannot be collateral damage in trade tensions.”

By Nick Paul Taylor • Aug. 22, 2025

More than 1,100 devices have received the FDA’s breakthrough designation

The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.

By Elise Reuter • Aug. 21, 2025

US, EU agree to terms of framework trade pact

The two trading partners documented provisions of a deal that would set a 15% tariff on many EU imports, including cars, auto parts, pharmaceuticals and semiconductors.

By Philip Neuffer • Aug. 21, 2025

AdvaMed urges Dr. Oz to speed Medicare coverage of breakthrough devices

The medtech trade group wants the CMS to take “bold action” to cut the lag between FDA authorization of devices and Medicare coverage.

By Nick Paul Taylor • Aug. 21, 2025

How Aktiia built the first over-the-counter cuffless blood pressure monitor

Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.

By Elise Reuter • Aug. 20, 2025

NeuroOne gains FDA clearance for trigeminal nerve ablation

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.

By Susan Kelly • Aug. 20, 2025

CMR Surgical hires Chris O’Hara to drive US robot expansion

O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization last fall for its Versius system.

By Susan Kelly • Aug. 19, 2025

Medtronic recall of heart vent catheters tied to 3 serious injuries

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being bent.”

By Nick Paul Taylor • Aug. 19, 2025

Heart devices pace medtech’s summer funding flows

July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting new technologies to treat heart conditions.

By Susan Kelly • Aug. 18, 2025

Philips will spend $150M to expand manufacturing for AI-enabled tech

The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, facility.

By Elise Reuter • Aug. 15, 2025

Trump says semiconductor tariffs to come next week

The president indicated that duties on chips would be “approximately 100%” earlier this month.

By Philip Neuffer • Aug. 15, 2025

Apple updates smart watches with blood oxygen feature after customs ruling

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

By Elise Reuter • Aug. 14, 2025

Reprieve Cardiovascular raises $61M; Conformal Medical nets $32M for LAAO

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused companies.

By Susan Kelly • Aug. 14, 2025

Vicarious Surgical delays robot timeline

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by the end of the year.

By Susan Kelly • Aug. 13, 2025

Shan Jegatheeswaran shares J&J’s vision for AI in the OR

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in procedures.

By Elise Reuter • Aug. 13, 2025

Cardiosense appoints John Martin as chief medical officer

The appointment comes weeks after the company received 510(k) clearance for its wearable heart monitor.

By Nick Paul Taylor • Aug. 13, 2025

Draeger removes ventilation filters over misleading carbon dioxide readings

Hospitals are being advised to stop using the filters after serious injuries were reported related to the problem, the FDA said in a recall notice.

By Elise Reuter • Aug. 12, 2025

Heartflow’s IPO raises $364M

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid investor enthusiasm.

By Nick Paul Taylor • Aug. 12, 2025

US to maintain lower tariff rates on China imports for 90 more days

China also extended its suspension of additional retaliatory duties against U.S. goods, maintaining current rates until November.

By Max Garland • Aug. 12, 2025

SetPoint Medical secures $140M to fund neuromodulation for arthritis

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.

By Susan Kelly • Aug. 11, 2025